Long-term Follow-up Observation After Surgical Treatment of Peri-implantitis in Multicenter Post Market Clinical Study
NCT ID: NCT03776097
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2015-12-31
2019-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Peri-implantitis Lesions by Using Biomaterial
NCT02375750
Long-term Surgical Treatment Outcome of Peri-implantitis Lesions
NCT05339789
Regenerative Treatment of Peri-implantitis
NCT06153212
The Influence of Implant Position on the Occurrence of Biological Complications
NCT05358782
Prospective Study to Evaluate the Performance and Safety of Personalized Implants in Cranio-Maxillofacial (CMF) Surgery Indicated for Orthognathic Surgery
NCT05073757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Defect Fill.
Observational study of the patients that were treated with biomaterials at the surgery in the previous study
observational study
Observational study
No defect Fill.observational
Observational study of the patients that were not treated with biomaterials at the surgery of te previous study
observational study
Observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational study
Observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
Exclusion Criteria
* Severe trauma to implant site causing removal of the implant since the last visit of previous study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geistlich Pharma AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Rasi, PhD
Role: STUDY_DIRECTOR
Geistlich Pharma
Stefan Renvert
Role: PRINCIPAL_INVESTIGATOR
Kristianstadt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kristianstad University
Kristianstad, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23530231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.